Saint Michael's Receives Approval to Help Community Members Manage Diabetes and Hypertension

Saint Michael's Receives Approval to Help Community Members Manage Diabetes and Hypertension

05-06-2014

Saint Michael's Receives Approval to Help Community Members Manage Diabetes and Hypertension

Newark, NJ—Saint Michael’s Medical Center (SMMC) received approval by the State of New Jersey and Centers for Medicare and Medicaid Services (CMS) for the Delivery System Reform Incentive Payment (DSRIP) Program demonstration . The five-year demonstration is one component of New Jersey’s Comprehensive Medicaid Waiver, which provides hospitals with the opportunity to improve patient care for New Jersey’s low income population by incentivizing delivery system reform to improve access, enhance quality of care, and promote health for certain prevalent , chronic conditions in the state, such as diabetes and hypertension.

According to the American Diabetes Association, more than 25 million people in the U.S. have diabetes. SMMC’s application to “Improve the Overall Quality of Care for Patients with Diabetes and Hypertension” was selected based on a comprehensive community needs assessment which identified this chronic condition as opportunity to fill an unmet need for access to care and service in the local Newark community—diabetes is the sixth leading cause of death in the community.

Slated to begin in the fall of 2014, SMMC will implement a patient-centered medical “home” for patients with diabetes and hypertension, based in the Medical Center’s Primary Care Center. Some highlights of the program will include community health screenings and education, referrals and access to needed health care services, focus on lifestyle modification and nutritional counseling, and offer a dedicated patient navigation system as well as assistance with social services.

“The project seeks to improve the health of the community by providing greater access to primary and specialty care, ultimately reducing costly admissions, readmissions, emergency department visits and length of stay for patients with diabetes and hypertension,” said David A. Ricci, President and CEO, SMMC. “Additionally, we will implement specific clinical quality measures to monitor improvement in the health outcome for the program’s patients.”

A steering committee consisting of hospital members, physicians and community partners will monitor the five-year project. The DSRIP program supports the Healthy New Jersey 2020 vision: “For New Jersey to be a state in which all people live long, healthy lives.”

Established by the Franciscan Sisters of the Poor in 1867, Saint Michael’s Medical Center is a 357-bed regional tertiary-care, teaching, and research center in the heart of Newark’s business and educational district. Saint Michael’s Medical Center is currently a member of CHE-Trinity Health. More information is available atwww.smmcnj.org.

Contact:

Cathy Toscano
Director of Communications
Marketing and Public Relations
Saint Michael’s Medical Center
(O): 973.596.3804 / (C): 973.803.2055
ctoscano@smmcnj.org

Categories: News